First-in-Class Drug Thwarts Hemolytic Anemia in Adults With PK Deficiency

(MedPage Today) -- Treatment with mitapivat (Pyrukynd) increased hemoglobin levels and decreased hemolysis in patients with pyruvate kinase (PK) deficiency who did not require regular blood transfusions, the randomized ACTIVATE trial showed. For...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news